Results 191 to 200 of about 12,412 (210)

Secukinumab

Reactions Weekly, 2018
  +8 more sources

Secukinumab

Reactions Weekly, 2021
  +4 more sources

Secukinumab

Reactions Weekly, 2019
  +8 more sources

Secukinumab

Reactions Weekly, 2023
  +4 more sources

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience

Clinical, Cosmetic and Investigational Dermatology, 2023
Alessia Villani, Maria Carmela Annunziata, Claudio Marasca   +2 more
exaly  

Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis

Journal of Dermatological Treatment, 2020
Andreas Pinter, Sascha Gerdes, Maximilian Reinhardt   +2 more
exaly  

Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks

Journal of Investigative Dermatology, 2019
Diamant Thaci, Esther von Stebut, Venkatesh Mani   +2 more
exaly  

Population Pharmacokinetic Modeling of Secukinumab in Patients With Moderate to Severe Psoriasis

Journal of Clinical Pharmacology, 2017
Gerard Bruin, Judit Nyirády
exaly  

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

Dermatology and Therapy, 2017
Ronald Vender, Yves Poulin, Richard Langley   +2 more
exaly  

Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study

Dermatologic Therapy, 2017
Claus Zachariae, Mads Rasmussen, Robert Gniadecki   +2 more
exaly